CLINICAL RESEARCH: MYOCARDIAL INFARCTION
Functional Status and Quality of Life After Emergency Revascularization for Cardiogenic Shock Complicating Acute Myocardial Infarction
Lynn A. Sleeper, ScD*,*,
Krishnan Ramanathan, MD ,
Michael H. Picard, MD ,
Thierry H. LeJemtel, MD ,
Harvey D. White, MD||,
Vladimir Dzavik, MD¶,
Deborah Tormey, RN#,
Nancy E. Avis, PhD**,
Judith S. Hochman, MD for the SHOCK Investigators
* New England Research Institutes, Watertown, Massachusetts
New York University School of Medicine, New York, New York
Massachusetts General Hospital, Boston, Massachusetts
Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York
|| Department of Cardiology, Auckland City Hospital, Auckland, New Zealand
¶ Toronto General Hospital, Toronto, Ontario, Canada
# St. Lukes/Roosevelt Hospital Center, New York, New York
** Wake Forest University Health Sciences, Winston-Salem, North Carolina.
Manuscript received November 4, 2004;
revised manuscript received January 7, 2005,
accepted January 11, 2005.
* Reprint requests and correspondence: Dr. Lynn A. Sleeper, New England Research Institutes, 9 Galen Street, Watertown, Massachusetts 02472. (Email: lsleeper{at}neriscience.com).
OBJECTIVES: Our goal was to describe the functional status of cardiogenic shock survivors, identify the correlates of cardiogenic shock, and compare global quality of life and functional status of patients randomly assigned to treatment with emergency revascularization (ERV) versus initial medical stabilization (IMS).
BACKGROUND: Historically, the hospital survival rate of patients with cardiogenic shock complicating acute myocardial infarction (MI) has been very low. Shock survivors are salvaged from a critically ill state, and their later functional status is not well documented. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK (SHOCK) trial showed significantly improved one-year survival after ERV compared with IMS.
METHODS: The SHOCK trial survivors completed interviews at 2 weeks after discharge and at 6 and 12 months after MI. Functional status assessment included the Multidimensional Index of Life Quality and New York Heart Association (NYHA) congestive heart failure functional class.
RESULTS: Eighty-seven percent of one-year survivors of the SHOCK trial were in NYHA functional class I or II. Between two weeks after discharge and one year after MI, improvement was similar in the two treatment groups (18% overall), but fewer patients remained stable (44% vs. 71%), and more patients worsened or died (34% vs. 15%) in the IMS group compared with those assigned to ERV. Assignment to ERV was the only independent predictor of outcome at one year.
CONCLUSIONS: Although one-year mortality after ERV is still high (54%), most survivors have good functional status. The ERV patients have a lower rate of deterioration than IMS patients. The level of recovery for shock patients undergoing ERV is similar to that of historical controls not in cardiogenic shock undergoing elective revascularization.
|
Abbreviations and Acronyms
| | ERV = emergency revascularization | | IMS = initial medical stabilization | | MI = myocardial infarction | | MILQ = Multidimensional Index of Life Quality | | NYHA = New York Heart Association | | SHOCK = SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK |
|
Related Article
-
Improving Quality of Life After Cardiogenic Shock: Do More Revascularization!
- E. Magnus Ohman and Patricia P. Chang
J. Am. Coll. Cardiol. 2005 46: 274-276.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. E. O'Connor, W. Brady, S. C. Brooks, D. Diercks, J. Egan, C. Ghaemmaghami, V. Menon, B. J. O'Neil, A. H. Travers, and D. Yannopoulos
Part 10: Acute Coronary Syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Circulation,
November 2, 2010;
122(18_suppl_3):
S787 - S817.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hagl, N. Khaladj, S. Peterss, A. Martens, I. Kutschka, H. Goerler, M. Shrestha, and A. Haverich
Acute Treatment of ST-Segment-Elevation Myocardial Infarction: Is There a Role for the Cardiac Surgeon?
Ann. Thorac. Surg.,
December 1, 2009;
88(6):
1786 - 1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hochman and A. H. Skolnick
Contemporary Management of Cardiogenic Shock: Age Is Opportunity
J. Am. Coll. Cardiol. Intv.,
February 1, 2009;
2(2):
153 - 155.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Lindholm, S. Boesgaard, J. J. Thune, H. Kelbaek, H. R. Andersen, L. Kober, and DANAMI-2 investigators
Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis
Eur J Heart Fail,
July 1, 2008;
10(7):
668 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Mehta, J. D. Grab, S. M. O'Brien, D. D. Glower, C. K. Haan, J. S. Gammie, E. D. Peterson, and on Behalf of the Society of Thoracic Surgeons Nati
Clinical Characteristics and In-Hospital Outcomes of Patients With Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Insights From the Society of Thoracic Surgeons National Cardiac Database
Circulation,
February 19, 2008;
117(7):
876 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Reynolds and J. S. Hochman
Cardiogenic Shock: Current Concepts and Improving Outcomes
Circulation,
February 5, 2008;
117(5):
686 - 697.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hochman and R. Apolito
The Calm After the Storm: Long-Term Survival After Cardiogenic Shock
J. Am. Coll. Cardiol.,
October 30, 2007;
50(18):
1759 - 1760.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Krumholz and F. A. Masoudi
The Year in Epidemiology, Health Services Research, and Outcomes Research
J. Am. Coll. Cardiol.,
November 7, 2006;
48(9):
1886 - 1895.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hochman, L. A. Sleeper, J. G. Webb, V. Dzavik, C. E. Buller, P. Aylward, J. Col, H. D. White, and for the SHOCK Investigators
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.
JAMA,
June 7, 2006;
295(21):
2511 - 2515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
184 - 202.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. White, S. F. Assmann, T. A. Sanborn, A. K. Jacobs, J. G. Webb, L. A. Sleeper, C.-K. Wong, J. T. Stewart, P. E.G. Aylward, S.-C. Wong, et al.
Comparison of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting After Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results From the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial
Circulation,
September 27, 2005;
112(13):
1992 - 2001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Ohman and P. P. Chang
Improving Quality of Life After Cardiogenic Shock: Do More Revascularization!
J. Am. Coll. Cardiol.,
July 19, 2005;
46(2):
274 - 276.
[Full Text]
[PDF]
|
 |
|
|